Development and validation of a procedure to isolate viable bone marrow cells from the vertebrae of cadaveric organ donors for composite organ grafting

References

• Strong DM. The US Navy Tissue Bank: 50 years on the cutting edge. Cell Tissue Bank. 2000;1:9–16.
   Google Scholar
• Sharp TG, Sachs DH, Matthews JG, Maples J, Woody JN, Rosenberg SA. Harvest of human bone marrow directly from bone. J Immunol Methods. 1984;69:187–95.
   Google Scholar
• Gao IK, Noga SJ, Wagner JE, Cremo CA, Davis J, Donnenberg AD. Implementation of a semiclosed large scale counterflow centrifugal elutriation system. J Clin Apheresis. 1987; 3:154–60.
   Google Scholar
• Kashiwagi N, Porter KA, Penn I, Brettschneider L, Starzl TE. Studies of homograft sex and of gamma globulin phenotypes after orthotopic homotransplantation of the human liver. Surg Forum. 1969;20:374–6.
   Google Scholar
• Starzl TE, Demetris AJ, Trucco M, Murase N, Ricordi C, Ildstad S, . Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology. 1993;17:1127–52.
   PubMed Web of Science ®Google Scholar
• Fontes P, Rao AS, Carroll P, Dodson F, Shapiro R, Tzakis A, . Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation. Lancet. 1994;344:151–5.
   PubMed Web of Science ®Google Scholar
• Fontes P, Rao AS, Reyes J, Furukawa H, Abu-Elmagd K, Jabbour N, . Concomitant infusion of unmodified donor bone marrow into unconditioned recipients of intestinal allografts. Transplant Proc. 1996;28:2757–8.
   Google Scholar
• Rao AS, Fontes P, Dodson F, Zeevi A, Rugeles MT, Abu-Elmagd K, . Augmentation of natural chimerism with donor bone marrow in orthotopic liver recipients. Transplant Proc. 1996;28:2959–65.
   Google Scholar
• Rao AS, Fontes P, Iyengar A, Shapiro R, Dodson F, Corry R, . Augmentation of chimerism with perioperative donor bone marrow infusion in organ transplant recipients: a 44 month follow-up. Transplant Proc. 1997;29:1184–5.
   PubMedGoogle Scholar
• Rao AS, Phil D, Fontes P, Iyengar A, Aitouche A, Shapiro R, . An attempt to induce tolerance with infusion of donor bone marrow in organ allograft recipients. Adv Exp Med Biol. 1997;417:269–74.
   Google Scholar
• Murase N, Ye Q, Nalesnik MA, Demetris AJ, Abu-Elmagd K, Reyes J, . Immunomodulation for intestinal transplantation by allograft irradiation, adjunct donor bone marrow infusion, or both. Transplantation. 2000;70: 1632–41.
   Google Scholar
• Sahota A, Gao S, Hayes J, Jindal RM. Microchimerism and rejection: a meta-analysis. Clin Transplant. 2000;14:345–50.
   PubMedGoogle Scholar
• Starzl TE, Murase N. Microchimerism, macrochimerism, and tolerance. Clin Transplant. 2000;14:351–4.
   PubMed Web of Science ®Google Scholar
• Sutherland DR, Anderson L, Keeney M, Nayar R, Chin-Yee I. The ISHAGE guidelines for CD34 + cell determination by flow cytometry. International Society of Hematotherapy and Graft Engineering. J Hematother. 1996;5:213–26.
   PubMedGoogle Scholar
• Donnenberg AD, Koch EK, Griffin DL, Stanczak HM, Kiss JE, Carlos TM, . Viability of cryopreserved BM progenitor cells stored for more than a decade. Cytotherapy. 2002;4: 157–63.
   PubMed Web of Science ®Google Scholar
• Wilkinson L. Systat, the System for Statistics. 12 ed. Chicago: Systat Software Inc.; 2007.
   Google Scholar
• Bender JG, To LB, Williams S, Schwartzberg LS. Defining a therapeutic dose of peripheral blood stem cells. J Hematother. 1992;1:329–41.
   PubMedGoogle Scholar
• Zimmerlin L, Donnenberg VS, Pfeifer ME, Meyer EM, Peault B, Rubin JP, . Stromal vascular progenitors in adult human adipose tissue. Cytometry A. 2010;77A:22–30.
   Google Scholar
• Donnenberg AD, Donnenberg VS, Griffin DL, Moore LR, Tekinturhan F, Kormos RL. Intra-operative preparation of autologous bone marrow-derived CD34-enriched cellular products for cardiac therapy. Cytotherapy. 2011;13: 441–8.
   PubMed Web of Science ®Google Scholar
• Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, . Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation. 2002;73:1386–91.
   PubMed Web of Science ®Google Scholar
• Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005;105:1815–22.
   PubMed Web of Science ®Google Scholar
• Fontes P, Rao AS, Ricordi C, Rybka WB, Dodson FS, Broznick B, . Human bone marrow obtained from vertebral bodies: cell isolation, phenotyping, progenitor assay, and transplantation. Transplant Proc. 1994;26:3406–7.
   Google Scholar
• Ahrens N, Tormin A, Paulus M, Roosterman D, Salama A, Krenn V, . Mesenchymal stem cell content of human vertebral bone marrow. Transplantation. 2004;78:925–9.
   PubMedGoogle Scholar